Back to UBS Group AG UBS Group AG

RGENRGEN
Showing 8 of 30 quarters

Position history for UBS Group AGUBS Group AG's holdings in REPLIGEN CORP

UBS Group AG holds 795,009 shares of RGEN (REPLIGEN CORP), worth $108.5M as of 2026-Q2. The position was increased (+18.6% shares). RGEN represents 0.0% of UBS Group AG's portfolio.

Current Value

$108.5M

Current Shares

795,009

Total Value Change

+$100.6M

Total Shares Change

+742,006

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
795,009
+18.6%
$108.5M0.0%$136.44
35
2026-Q1
Increased
670,329
+92.4%
$79M0.0%$123.06
47
2025-Q4
Decreased
348,388
-23.8%
$57.1M0.0%$166.59
0
2025-Q3
Increased
456,929
+54.8%
$61.1M0.0%$124.09
42
2025-Q2
Increased
295,198
+22.4%
$36.7M0.0%$123.56
35
2025-Q1
Increased
241,074
+27.7%
$30.7M0.0%$133.41
36
2024-Q4
Increased
188,811
+256.2%
$27.2M0.0%$143.81
46
2024-Q3
Decreased
53,003
-28.3%
$7.9M0.0%$145.93
0

Other major holders of RGEN: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used